
Oxaliplatin (Eloxatin) is a novel antineoplastic platinum derivative that may exert its cytotoxic effects by blocking DNA replication/transcription, thus resulting in cell death in proliferating cells, as well as apoptosis.

Your AI-Trained Oncology Knowledge Connection!


Published: December 1st 2000 | Updated: